Ines Godet (Inês Godet)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Cancers

Molecular cancer research : MCR

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

Johns Hopkins University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Johns Hopkins University Jan 20 2016

United States

PHD :: Chemical and Biomolecular Engineering

Instituto Superior Técnico Sep 01 2013 - Nov 12 2015

Portugal

MSC :: Bioengineering

Instituto Superior Técnico Sep 01 2010 - Jun 30 2013

Portugal

BSC :: Bioengineering

Publications

Jeanette A I Johnson, Genevieve L Stein-O'Brien, Max Booth, Randy Heiland, Furkan Kurtoglu, Daniel R Bergman, Elmar Bucher, Atul Deshpande, André Forjaz, Michael Getz, Ines Godet, Melissa R Lyman, John Metzcar, Jacob T Mitchell, Andrew D Raddatz, Heber L Rocha, Jacobo Solorzano, Aneequa Sundus, Yafei Wang, Daniele M Gilkes, Luciane Tsukamoto Kagohara, Ashley L Kiemen, Elizabeth D Thompson, Denis Wirtz, Pei-Hsun Wu, Neeha Zaidi, Lei Zheng, Jacquelyn W Zimmerman, Elizabeth D Thompson, Young Hwan Chang, Lisa M Coussens, Joe W Gray, Laura M Heiser, Elana J Fertig, Paul Macklin
Digitize your Biology! Modeling multicellular systems through interpretable cell behavior. bioRxiv : the preprint server for biology (2023)
Natalie S Joe, Yuanfeng Wang, Harsh H Oza, Ines Godet, Nubaira Milki, Gregory J Riggins, Daniele M Gilkes
Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells. Cancers 15 (4) (2023)
Natalie S Joe, Yuanfeng Wang, Harsh H Oza, Ines Godet, Nubaira Milki, Gregory J Riggins, Daniele M Gilkes
Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells. Cancers 15 (4) (2023)
Natalie S Joe, Yuanfeng Wang, Harsh H Oza, Ines Godet, Nubaira Milki, Gregory J Riggins, Daniele M Gilkes
Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells. Cancers 15 (4) (2023)
Omkar Bhatavdekar, Ines Godet, Daniele M Gilkes, Stavroula Sofou
The Rate of Cisplatin Dosing Affects the Resistance and Metastatic Potential of Triple Negative Breast Cancer Cells, Independent of Hypoxia. Pharmaceutics 14 (10) (2022)
Ines Godet, Steven Doctorman, Fan Wu, Daniele M Gilkes
Detection of Hypoxia in Cancer Models: Significance, Challenges, and Advances. Cells 11 (4) (2022)
Ines Godet, Mahelet Mamo, Andrea Thurnheer, D Marc Rosen, Daniele M Gilkes
Post-Hypoxic Cells Promote Metastatic Recurrence after Chemotherapy Treatment in TNBC. Cancers 13 (21) (2021)
Ru Wang, Ines Godet, Yongkang Yang, Shaima Salman, Haiquan Lu, Yajing Lyu, Qiaozhu Zuo, Yufeng Wang, Yayun Zhu, Chelsey Chen, Jianjun He, Daniele M Gilkes, Gregg L Semenza
Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis. Proceedings of the National Academy of Sciences of the United States of America 118 (19) (2021)
Josh W DiGiacomo, Ines Godet, Michael Trautmann-Rodriguez, Daniele M Gilkes
Extracellular Matrix-Bound FGF2 Mediates Estrogen Receptor Signaling and Therapeutic Response in Breast Cancer. Molecular cancer research : MCR 19 (1) (2020)
Ines Godet, Yu Jung Shin, Julia A Ju, I Chae Ye, Guannan Wang, Daniele M Gilkes
Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis. Nature communications 10 (1) (2019)

Ines Godet.css-eqlu8i{font-size:small;padding-left:4px;} (Inês Godet)

Publication Activity (10 Years)

Top Topics

Top Venues

Ines Godet (Inês Godet)